243 related articles for article (PubMed ID: 7919388)
1. p22-phox-deficient chronic granulomatous disease: reconstitution by retrovirus-mediated expression and identification of a biosynthetic intermediate of gp91-phox.
Porter CD; Parkar MH; Verhoeven AJ; Levinsky RJ; Collins MK; Kinnon C
Blood; 1994 Oct; 84(8):2767-75. PubMed ID: 7919388
[TBL] [Abstract][Full Text] [Related]
2. Detection of gp91-phox precursor protein in B-cell lines from patients with X-linked chronic granulomatous disease as an indicator for mutations impairing cytochrome b558 biosynthesis.
Porter CD; Kuribayashi F; Parkar MH; Roos D; Kinnon C
Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):571-5. PubMed ID: 8615831
[TBL] [Abstract][Full Text] [Related]
3. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency.
Ishibashi F; Nunoi H; Endo F; Matsuda I; Kanegasaki S
Hum Genet; 2000 May; 106(5):473-81. PubMed ID: 10914676
[TBL] [Abstract][Full Text] [Related]
4. Missense mutations in the gp91-phox gene encoding cytochrome b558 in patients with cytochrome b positive and negative X-linked chronic granulomatous disease.
Kaneda M; Sakuraba H; Ohtake A; Nishida A; Kiryu C; Kakinuma K
Blood; 1999 Mar; 93(6):2098-104. PubMed ID: 10068684
[TBL] [Abstract][Full Text] [Related]
5. X-linked chronic granulomatous disease: correction of NADPH oxidase defect by retrovirus-mediated expression of gp91-phox.
Porter CD; Parkar MH; Levinsky RJ; Collins MK; Kinnon C
Blood; 1993 Oct; 82(7):2196-202. PubMed ID: 8400270
[TBL] [Abstract][Full Text] [Related]
6. Biosynthesis of the phagocyte NADPH oxidase cytochrome b558. Role of heme incorporation and heterodimer formation in maturation and stability of gp91phox and p22phox subunits.
Yu L; Zhen L; Dinauer MC
J Biol Chem; 1997 Oct; 272(43):27288-94. PubMed ID: 9341176
[TBL] [Abstract][Full Text] [Related]
7. Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly.
Leusen JH; Meischl C; Eppink MH; Hilarius PM; de Boer M; Weening RS; Ahlin A; Sanders L; Goldblatt D; Skopczynska H; Bernatowska E; Palmblad J; Verhoeven AJ; van Berkel WJ; Roos D
Blood; 2000 Jan; 95(2):666-73. PubMed ID: 10627478
[TBL] [Abstract][Full Text] [Related]
8. Long-term high-level reconstitution of NADPH oxidase activity in murine X-linked chronic granulomatous disease using a bicistronic vector expressing gp91phox and a Delta LNGFR cell surface marker.
Sadat MA; Pech N; Saulnier S; Leroy BA; Hossle JP; Grez M; Dinauer MC
Hum Gene Ther; 2003 May; 14(7):651-66. PubMed ID: 12804147
[TBL] [Abstract][Full Text] [Related]
9. Mutation at histidine 338 of gp91(phox) depletes FAD and affects expression of cytochrome b558 of the human NADPH oxidase.
Yoshida LS; Saruta F; Yoshikawa K; Tatsuzawa O; Tsunawaki S
J Biol Chem; 1998 Oct; 273(43):27879-86. PubMed ID: 9774399
[TBL] [Abstract][Full Text] [Related]
10. Hypoxic induction of gene expression in chronic granulomatous disease-derived B-cell lines: oxygen sensing is independent of the cytochrome b558-containing nicotinamide adenine dinucleotide phosphate oxidase.
Wenger RH; Marti HH; Schuerer-Maly CC; Kvietikova I; Bauer C; Gassmann M; Maly FE
Blood; 1996 Jan; 87(2):756-61. PubMed ID: 8555500
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation at a probable heme-binding ligand in neutrophil cytochrome b558 in atypical X-linked chronic granulomatous disease.
Tsuda M; Kaneda M; Sakiyama T; Inana I; Owada M; Kiryu C; Shiraishi T; Kakinuma K
Hum Genet; 1998 Oct; 103(4):377-81. PubMed ID: 9856476
[TBL] [Abstract][Full Text] [Related]
12. Stoichiometry of p22-phox and gp91-phox in phagocyte cytochrome b558.
Huang J; Hitt ND; Kleinberg ME
Biochemistry; 1995 Dec; 34(51):16753-7. PubMed ID: 8527449
[TBL] [Abstract][Full Text] [Related]
13. Cloning and sequencing of the bovine flavocytochrome b subunit proteins, gp91-phox and p22-phox: comparison with other known flavocytochrome b sequences.
Davis AR; Mascolo PL; Bunger PL; Sipes KM; Quinn MT
J Leukoc Biol; 1998 Jul; 64(1):114-23. PubMed ID: 9665285
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay.
Jirapongsananuruk O; Malech HL; Kuhns DB; Niemela JE; Brown MR; Anderson-Cohen M; Fleisher TA
J Allergy Clin Immunol; 2003 Feb; 111(2):374-9. PubMed ID: 12589359
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and identification of bottle-nosed dolphin flavocytochrome b gp91(phox) and p22(phox) subunits.
Inoue Y; Itou T; Jimbo T; Sakai T; Ueda K; Imajoh-Ohmi S; Iida T
Vet Immunol Immunopathol; 2000 Aug; 76(1-2):137-50. PubMed ID: 10973692
[TBL] [Abstract][Full Text] [Related]
16. Long-term correction of phagocyte NADPH oxidase activity by retroviral-mediated gene transfer in murine X-linked chronic granulomatous disease.
Dinauer MC; Li LL; Björgvinsdóttir H; Ding C; Pech N
Blood; 1999 Aug; 94(3):914-22. PubMed ID: 10419882
[TBL] [Abstract][Full Text] [Related]
17. The arachidonate-activable, NADPH oxidase-associated H+ channel. Evidence that gp91-phox functions as an essential part of the channel.
Henderson LM; Banting G; Chappell JB
J Biol Chem; 1995 Mar; 270(11):5909-16. PubMed ID: 7890722
[TBL] [Abstract][Full Text] [Related]
18. Mapping sites of interaction of p47-phox and flavocytochrome b with random-sequence peptide phage display libraries.
DeLeo FR; Yu L; Burritt JB; Loetterle LR; Bond CW; Jesaitis AJ; Quinn MT
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):7110-4. PubMed ID: 7624379
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells.
Bayraktutan U; Blayney L; Shah AM
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1903-11. PubMed ID: 10938010
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody 7D5 recognizes the R147 epitope on the gp91
Kawai C; Yamauchi A; Kuribayashi F
Microbiol Immunol; 2018 Apr; 62(4):269-280. PubMed ID: 29573449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
